Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-1072

General request regarding RxNorm codes in value sets

XMLWordPrintable

    • Icon: Value Sets Value Sets
    • Resolution: Answered
    • Icon: Minor Minor
    • ValueSet
    • None
    • Hide
      The "general" representation of medications has been deemed the best way for standardized drug content to be represented. It is a given that for many situations, this one included, that implementers may have to use up to date mapping to render content that exists in the native clinical system, into a form that is "standardized". The use of the more general form of clinical drugs lessens the burden on implementers to keep value sets up to date given that brand name representations change much more frequently than the generalize concept.

      Over time, as systems improve such that the frequent (as often as weekly) changes are easily created and consumed, the approach outlined could be re-evaluated.

      The policy to use generic drugs and not branded ones also aligns with a CMS policy to move away from the description of medications using the brand titles and has been in place since the start of Stage 2 MU. If you have further feedback regarding any hardship this causes you we are happy to receive this feedback.
      Show
      The "general" representation of medications has been deemed the best way for standardized drug content to be represented. It is a given that for many situations, this one included, that implementers may have to use up to date mapping to render content that exists in the native clinical system, into a form that is "standardized". The use of the more general form of clinical drugs lessens the burden on implementers to keep value sets up to date given that brand name representations change much more frequently than the generalize concept. Over time, as systems improve such that the frequent (as often as weekly) changes are easily created and consumed, the approach outlined could be re-evaluated. The policy to use generic drugs and not branded ones also aligns with a CMS policy to move away from the description of medications using the brand titles and has been in place since the start of Stage 2 MU. If you have further feedback regarding any hardship this causes you we are happy to receive this feedback.

      We would like to make a general request concerning RxNorm codes. The data required for CQMs should be at the granularity and specificity as collected in clinical practice. So if in clinical practice, branded and generic drug names are used, both should be included in the CQM value sets.

      In many of the current CQM value sets, only the Sematic Clinical Drug codes are included. We propose that Semantic Branded Drug Component codes should also be included to the value sets so that hospitals and providers who use branded drugs can pass these measures.

            rob.mcclure Rob McClure (Inactive)
            siemens Siemens (Inactive)
            carol (Inactive), Minet Javellana (Inactive), Rabia Khan (Inactive)
            Votes:
            3 Vote for this issue
            Watchers:
            8 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On:
              Comment Posted On: